New Delhi: Former Health Minister Anbumani Ramadoss is under CBI scanner with the agency finalising its charge sheet which names him for his alleged help to a Indore based medical college to get MCI accreditation even though it was not eligible for the same. The agency has sought government nod for prosecution of two Health Ministry officials: a Deputy Secretary and an under secretary and two doctors of Safdarjung Medical...
11:06 PM, Mar 05, 2012
Washington: Indian pharma major Ranbaxy faces the possibility of a permanent injunction, which requires it to make fundamental changes to its plants both in the US and India and would prevent it from manufacturing drugs at certain facilities in the US. This follows the US Justice Department's unprecedented action in filing a ground-breaking consent decree in a court in Maryland at the request of the Food and Drug Administration. "This...
06:00 PM, Jan 26, 2012
New Delhi: The Supreme Court on Thursday told the central government that the prices of medicines should not rise further. "Bring it down, don't escalate it in the name of policy," the court said. "It should go down, not go up," said the apex court bench of Justice GS Singhvi and Justice SJ Mukhopadhaya. The bench said that the prices of medicines and lab tests were already too high and...
11:03 AM, Nov 18, 2011
Yashmin demands up gradation of facilities at Safdarjung hospital, the only govt burns care specialty hospital. ...
12:27 PM, Oct 22, 2011
Washington: An Indian-American couple in New Jersey has pleaded guilty before a US court for selling counterfeit prescription drugs made in India, federal authorities said. The couple, 47-year-old Nita Patel and 57-year-old Harshad Patel, offered 'generic' forms of patented pharmaceutical products for sale over the internet, the source of which was an Indian company, court documents said. They face a maximum of 10 years of jail prison and a $250,000...
08:40 AM, May 17, 2011
New Delhi: A Delhi University student was shot dead outside her college in Dhaula Kuan on Tuesday. Radhika Tanwar, a resident of Naraina, was a second year Bachelor of Arts (BA) student of Ram Lal Anand College. The girl was rushed to Safdarjung hospital after she was shot at on the Dhaula Kuan foot-over bridge, where she succumbed to her injuries and was declared dead. Reports suggest that the killer...
12:31 PM, Mar 08, 2011
Mumbai: The Food and Drug Administration has begun to investigate the quality of drugs purchased by Lilavati Hospital, just days after CNN-IBN exposed money-laundering at the hospital. CNN-IBN, in its report, had shown that Lilavati Hospital sourced medicines from 400 small individual medical stores, 250 of which are located in the slums of Dharavi. Prabodh Kiritilal Mehta and Rashmi Kiritilal Mehta - exposed recently by CNN-IBN - figure in a...
09:34 AM, Feb 23, 2011
Boston: Regeneron Pharmaceuticals Inc said on Monday that US regulators placed the company's experimental pain drug for osteoarthritis on clinical hold after a patient in another company's trial developed a serious bone disorder. Regeneron said it and its partner, Sanofi-Aventis SA, were informed late last week by the US Food and Drug Administration that the drug, REGN475/SAR164877, was being placed on clinical hold after a patient in another company's trial...
09:53 AM, Dec 28, 2010
Washington: The Food and Drug Administration said Wednesday that Abbott Laboratories is recalling up to 359 million testing strips used by diabetics because they can give falsely low blood sugar readings. The testing strips are used to help diabetes patients check their blood sugar levels. But the FDA says the products being recalled by Abbott can give inaccurately low measurements. As a result, patients may try to raise their blood...
01:51 PM, Dec 23, 2010
Washington: US health officials are taking a closer look at recombinant human growth hormone products made by Pfizer, Novartis and other drugmakers to see whether they increase the risk of death. The move comes on the heels of a French study that found certain children given the hormone had "a small increased risk of death" compared with the overall population, the Food and Drug Administration said in a statement on...
12:46 PM, Dec 23, 2010
Silver Spring Maryland: The first new weight-loss pill in a decade moved closer to US approval on Tuesday, when a panel of expert advisers backed Orexigen Therapeutics's Contrave despite heart risk concerns. It was the third new weight-loss drug to come before U.S. regulators this year, the Food and Drug Administration having rejected two rival medicines in October. Orexigen's stock more than doubled to USD 12.20 from Monday's close of...
04:09 PM, Dec 08, 2010
Doctors at New Delhi's Safdarjung Hospital had gone on a 2 day strike demanding better security. ...
10:12 PM, Sep 08, 2010
Relief for patients as Safdarjang Hospital doctors end strike after security assurances. ...
03:35 PM, Sep 08, 2010
New Delhi: Nearly 1200 resident doctors of Safdarjung Hospital in the city, on an indefinite strike for two days demanding adequate security, on Wednesday called off their agitation following assurances from authorities that their demand will be met. "The issue has been resolved amicably and the strike has been called off," N K Mohanty, Medical Superintendent of the hospital, said after a meeting with the agitating doctors. He said that...
03:03 PM, Sep 08, 2010
The doctors meanwhile have set up a temporary OPD outside the hospital to treat emergency cases. ...
12:59 PM, Sep 08, 2010
displayed with permission. Use of the CNN name and/or logo on or as part of CNN-IBN does not derogate from the intellectual property rights of Cable News Network in respect of them.
Disclaimer: Network18 Media & Investments Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
Disclaimer: TV18 Broadcast Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
